27.11.2017 20:15:00

Global Atherectomy Devices Market Forecasts To 2022 - Major Players are Medtronic, Philips, Boston Scientific, Cardiovascular Systems, Straub Medical, BIOTRONIK, C.R. Bard & Avinger

DUBLIN, November 27, 2017 /PRNewswire/ --

The "Atherectomy Devices Market - Global Forecasts To 2022" report has been added to Research and Markets' offering.

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%.

The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

This report broadly segments the atherectomy devices market into product, application, end user, and region. On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market.

It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.

The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

Market Dynamics

Drivers

  • Growing Target Patient Population
  • Continuous Product Development and Commercialization
  • Favorable Medical Reimbursement Scenario in Mature Markets
  • Rising Demand for Minimally Invasive Surgical Procedures
  • Strengthening Distribution Channels of Major Product Manufacturers

Restraints

  • Limited Patient Awareness Related to Disease Diagnosis
  • Stringent Regulatory Scenario
  • Dearth of Skilled and Well-Trained Surgeons

Opportunities

  • Increasing Number of Research Activities in the Field of Atherectomy
  • Increasing Healthcare Expenditure Across Emerging Markets

Challenges

  • Significant Adoption of Alternative Therapies

Key Topics Covered:

1 Atherectomy Devices Market: Introduction

2 Atherectomy Devices Market: Research Methodology

3 Atherectomy Devices Market: Executive Summary

4 Atherectomy Devices Market: Premium Insights

5 Atherectomy Devices Market: Overview

6 Global Atherectomy Devices Market, By Product

7 Global Atherectomy Devices Market, By Application

8 Global Atherectomy Devices Market, By End User

9 Atherectomy Devices Market, By Region

10 Atherectomy Devices Market: Competitive Landscape

11 Atherectomy Devices Market: Company Profiles

  • Abbott Laboratories
  • Avinger
  • B. Braun Group
  • Biomerics
  • Biotronik
  • Boston Scientific
  • C.R. Bard
  • Cardinal Health
  • Cardiovascular Systems
  • Koninklijke Philips
  • Medtronic
  • Minnetronix, Inc.
  • RA Medical Systems
  • Straub Medical
  • Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/research/ft8jz6/atherectomy

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!